1st Quarter - Report

WILLIAMS AND JENSEN, PLLC for PFIZER

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

IP protections related to trade agreement.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
ERIN BOOK MULLEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare payment issues including the Independent Payment Advisory Board (IPAB) and Medicaid issues. Medicare Part D. CMMI Medicare Part B Demonstration.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —
ANDREW JONES Legislative Counsel, Rep. Hinojosa; Legislative Director and Counsel, Rep Lujan
KARINA LYNCH —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Tax issues affecting the pharmaceutical industry including international tax. Revenue proposals on international tax. Comprehensive tax reform proposals.

LobbyistCovered position, as disclosed
DENIS DWYER —
CHRISTOPHER W HATCHER —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Rebates for Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; H.R. 1628, American Health Care Act of 2017

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.